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Abstract 
Aim: Akkermansia muciniphila is a beneficial gut commensal, whose anti-inflammatory 
properties have recently been demonstrated. This study aimed to evaluate the effect of 
A.muciniphila on Porphyromonas gingivalis elicited inflammation.
Material and Methods: In lean and obese mice, A.muciniphila was administered in P.gingivalis 
induced calvarial abcess and in experimental periodontitis model (EIP). Bone destruction and 
inflammation were evaluated by histomorphometric analysis. In vitro, A.muciniphila was co-
cultured with P.gingivalis, growth and virulence factors expression were evaluated. Bone-marrow 
macrophages (BMMϕ) and gingival epithelial cells (TIGK) were exposed to both bacterial strains 
and the expression of inflammatory mediators, as well as tight junction markers was analyzed. 
Results: In a model of calvarial infection, A.muciniphila decreased inflammatory cell infiltration 
and bone destruction. In EIP, treatment with A.muciniphila resulted in a decreased alveolar bone 
loss. In vitro, the addition of A.muciniphila to P.gingivalis infected BMMϕ increased anti-
inflammatory IL-10 and decreased IL-12. Additionally, A.muciniphila exposure increases the 
expression of junctional integrity markers such as integrin-1, E-cadherin and ZO-1 in TIGK 
cells. A.muciniphila co-culture with P.gingivalis reduced gingipains mRNA expression. 
Discussion: This study demonstrated the protective effects of A.muciniphila administration and 
may open consideration to its use as an adjunctive therapeutic agent to periodontal treatment.  
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Clinical relevance: 
Scientific rationale for study: Akkermansia muciniphila, a gut symbiont and marker of health, 
displayed interesting anti-inflammatory properties at the gut level. 
Practical findings: We demonstrate its ability to counteract the periodontal destruction as well as 
inflammatory response induced by a major periodontal pathogen, Porphyromonas gingivalis. Such 
effects could be explained by strong anti-inflammatory effects induced by A.muciniphila exposure 
as observed in macrophages but also by reinforcement of epithelial junctional structures. 
Practical implications: These results may open new perspectives to the therapeutic administration 
of A.muciniphila as an adjunct to existing periodontal treatment protocols to improve treatment 
outcomes in at-risk patients.
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Introduction 
Periodontitis is a chronic inflammatory disease induced by pathogen-carrying microbial 
communities affecting tooth supporting tissues and is a major cause of tooth loss (Kinane, 
Stathopoulou, & Papapanou, 2017). For more than a decade, the bidirectional link between 
systemic inflammatory conditions and periodontitis has been studied (Linden, Lyons, & 
Scannapieco, 2013). Accordingly, a relationship between obesity and periodontitis has been 
suggested, as obese individuals are more prone to develop periodontitis in comparison with 
normal weight counterparts (Keller, Rohde, Raymond, & Heitmann, 2015; Nascimento et al., 
2015). Nevertheless, periodontal management of obese subjects is challenging, as they exhibit a 
reduced response to periodontal treatment, especially at deep sites (Bouaziz, Davideau, 
Tenenbaum, & Huck, 2015) highlighting the need for new treatment strategies. To improve 
periodontal treatment outcomes, adjunctive therapies have been proposed, such as the use of 
probiotics, for both obesity and periodontitis management (Cani & de Vos, 2017; Martin-Cabezas, 
Davideau, Tenenbaum, & Huck, 2016).
Akkermansia muciniphila, a mucophilic symbiont found in colon of healthy lean individuals, 
uses mucin as its primary carbon source, allowing it to survive in the gut during times of low nutrient 
availability (Derrien, Vaughan, Plugge, & de Vos, 2004). Current data indicates that a decline in 
A.muciniphila in the colon correlates with several inflammatory diseases, such as obesity, type-2 
diabetes, and inflammatory bowel disease (Cani & Everard, 2014; Derrien, Belzer, & de Vos, 2017; 
Png et al., 2010; Schneeberger et al., 2015). Hence, A.muciniphila has become a marker of a healthy 
microbiome and has been shown to adhere to the colonic epithelium, increasing the integrity of the 
intestinal barrier in human and mice as demonstrated in diet-induced obese animal models (Everard et 
al., 2013; Reunanen et al., 2015). The administration of A.muciniphila to obese animals has been 
shown to decrease serum LPS, adipose tissue macrophage infiltration, as well as total fat mass gain 
(Plovier et al., 2017). Based on the knowledge acquired so far, A.muciniphila may increase barrier 
function via its interaction with Toll-like receptor (TLR)-2 and other receptors contributing to a 
functional gastro-intestinal tract (Plovier et al., 2017; Ottman et al., 2017). This effect could be 
mediated by the recently discovered pili-like protein from A.muciniphila (Amuc_1100) that was found to 
be involved in immune regulation and enhancement of trans-epithelial resistance by modulating the 
expression of tight junction proteins (Plovier et al., 2017; Ottman et al., 2017). Of interest, A.muciniphila 
increased production of specific cytokines through activation of TLR-2 and TLR-4, inducing high levels 
of IL-10 similar to those induced by the other beneficial immune suppressive microorganisms such as A
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Lactobacillus plantarum (Ottman et al., 2017). While A.muciniphila is mainly present in the colon, it 
has also been found in the oral cavity at low levels, warranting further studies of its functionality at this 
site (Geerlings, Kostopoulos, de Vos, & Belzer, 2018).  Nevertheless, the anti-inflammatory 
properties and safety of administration of A.muciniphila have been demonstrated in a randomized 
clinical trial in human allowing the consideration of its use for inflammatory disease management 
(Depommier et al., 2019).
The aim of this study was to evaluate the therapeutic impact of A.muciniphila on P.gingivalis 
elicited inflammatory responses with the perspective of its potential use as an adjunct to 
periodontal treatment in both lean and obese individuals.
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Materials and methods
Bacterial cultures
Akkermansia muciniphila MucT (ATCC BAA-835) was grown anaerobically (N2/CO2 
(80 : 20, v/v)) in brain heart infusion broth (Criterion, Hardy diagnostics, CA, USA) supplemented 
with 3% hog gastric mucin (Type III, Sigma-Aldrich, St. Louis, MO, USA) as previously 
described (Derrien et al., 2004) and grown in 10 mL Hungate anaerobic tubes (Chemglass Life 
Sciences, NJ, USA). The concentration of bacteria was estimated by measuring absorbance at 600 
nm. Liquid cultures were washed and resuspended in sterile anaerobic PBS to the required 
concentration prior to each experiment.
The Porphyromonas gingivalis 381 strain was cultured and maintained in brain heart 
infusion media supplemented with hemin (5 g/mL, Sigma-Aldrich) and menadione (1 g/mL, 
Sigma-Aldrich) in an anaerobic environment (AnaeroPack-Anaero, Mitsubishi Gas Chemical Co., 
New York, NY, USA) at 370C for 48h as described previously (Alshammari et al., 2017). 
Animals
22 weeks-old C56/BL6 obese mice (C57/BL6 - DIO-B6-M) and lean C57/BL6 mice (B6-
DIOCONTROL-M) were obtained from Taconic Biosciences (NY, USA). All mice were housed 3 
per cage at the New York Medical College Animal Facility on a 12h light/dark cycle and ad 
libitum access to food and water. All animal procedures were approved by NYMC IACUC (#59-2-
1016H). Obese animals were maintained on a high fat diet (D12492; Research Diets, Inc., New 
Brunswick, NJ), in which 60% of kcal is from fat, while lean animals received a standard chow 
diet (5% kcal fat).
Mouse calvarial bone resorption model
Twenty-two weeks-old wild-type lean mice and matching high-fat-induced obese 
C57BL/6J mice were used. Mice were distributed into the following 4 treatment groups 
(n=6/group): (i) PBS, (ii) P.gingivalis alone, (iii) A.muciniphila alone and (iv)  P.gingivalis + 
A.muciniphila simultaneously. Mice were anesthetized by the intraperitoneal injection of 
ketamine-xylazine (Akorn Animal Health, Lake Forest, IL, USA). The heads of mice were shaved 
and P.gingivalis (5x108 CFU) and A.muciniphila (109 CFU) in 100l of PBS or PBS alone were 
injected subcutaneously in the 4 treatment groups with a 30.5-gauge needle at a point on the A
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midline of the skull between the ears and eyes (Huck et al., 2017; Huck et al., 2019). Lesions were 
evaluated each day for 5 days. Mice were euthanized 5 days post-injection. The size of the lesion 
resulting from the injection in each animal (area in square millimeters) was analyzed using ImageJ 
software.
Histological analysis
Dissected calvaria were fixed in 4% paraformaldehyde in PBS (Sigma-Aldrich) overnight 
at 4°C and decalcified after glycerol wash. Samples were stored at 4°C in 30 % sucrose/PBS until 
processing. Samples were embedded in Optimal Cutting Temperature embedding media (Fisher 
HealthCare, Suwanee, GA, USA) and frozen for cryostat sectioning. 5-10μm sections were stained 
with hematoxylin and eosin (H&E) (Fisher Scientific, Suwanee, GA, USA) and prepared for 
further analysis. To evaluate osteoclast activity, a tartrate-resistant acid phosphatase (TRAP) assay 
and scoring of inflammation and osteoclast activity was performed (Huck et al., 2017) (see 
Appendix).
Induction of periodontitis and A.muciniphila administration
Sterile black braided 6-0 silk sutures were incubated in P.gingivalis culture for 1 day in 
anaerobic conditions. Following anesthesia, P.gingivalis soaked 6-0 ligatures were placed in the 
sulcus around the maxillary first and second molars as previously described (Saadi-Thiers et al., 
2013). Ligatures were replaced 3 times/week during 3 weeks with fresh P.gingivalis soaked 
ligatures.  On days in between ligature placement, oral gavage with P.gingivalis (5x108 cells) was 
provided as previously described (Alshammari et al., 2017). After 3 weeks of periodontitis 
induction, therapeutic inoculation of A.muciniphila (109 cells) was administrated by daily gavage 
concomitantly with P.gingivalis for 2 additional weeks.
Morphometric analysis
Palatal bone was processed for morphometric analysis. After mechanical defleshing for 15 
min in boiling water, samples were washed in PBS and then exposed overnight in 3% hydrogen 
peroxide. The palatal bones were treated with 10% bleach for 1 min, washed with PBS 3 times for 
5 min and then dried at 37°C. Bone staining was performed at room temperature with 1% 
methylene blue (Sigma-Aldrich) for 1 min, after which specimens were washed and dried 30 min 
at 37°C (Alshammari et al., 2017). Bone loss was defined as the distance between cemento-enamel A
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junction (CEJ) and the most coronal alveolar bone. Measurements were taken at 6 sites from the 
mesial aspect of the first molar to the distal aspect of second molar. Bone loss was expressed as a 
mean +/-SD in m.
Periodontal histomorphometric analysis
Following euthanasia, the right side of the palatal bone and intact surrounding tissue was 
fixed with 4% freshly prepared paraformaldehyde (Sigma-Aldrich, St. Louis, MO) in PBS (pH 
7.2) for 24h at 4°C. Following fixation, specimens were decalcified and embedded for cryostat 
sectioning as previously described (Alshammari et al., 2017). A minimum of 6 fields from each 
interdental area (from CEJ to root apex of the second molar) were analyzed and inflammatory 
scoring as well as osteoclast scoring were performed (see Appendix) (Alshammari et al., 2017). 
Analysis of P.gingivalis -A.muciniphila interactions 
            Communities of P.gingivalis and A.muciniphila were anaerobically cultivated, stained with 
hexidium iodide (15 μg/mL, Invitrogen) and deposited on glass coverslips for 16h anaerobically at 
37°C. P.gingivalis (2.107) were labeled with 5-(and-6)-carboxyfluorescein, succinimidyl ester 
(FITC, 4 μg/mL, Invitrogen) and reacted with A.muciniphila for 18h in prereduced PBS 
anaerobically at 37°C with rocking. After washing with PBS, coverslips were examined on a Leica 
SP8 confocal microscope using 488 nm (FITC) and 558 nm (hexidium iodide) lasers. XYZ stacks 
were digitally reconstructed using Volocity software (Perkin Elmer). Quantitation of the volume 
of P.gingivalis fluorescence was obtained using the Find Objects algorithm in the Volocity 
program. This process analyzes all P.gingivalis fluorescence in the 3D digitally recreated confocal 
images. To estimate microcolony formation, the Find Objects process was used with a threshold 
for 3D objects greater than 30 μm3. Expression of P.gingivalis gingipaïns (Rgp A, Rgp B, Kgp) 
and A.muciniphila Amuc_1100 was determined by RT-qPCR (see Appendix).
Mouse bone marrow macrophages (BMMϕ)
BMMϕ were harvested as described previously (Zhang, Goncalves, & Mosser, 2008). 
Briefly, bone marrow cells from femurs from obese and lean mice were cultured in 30% L-929 
conditioned RPMI media at a density of 105 cells/mL (Weischenfeldt & Porse, 2008). After one 
week in culture, cells had differentiated into BMMϕ. One day prior to experiments, cell culture 
medium was changed with fresh 30% L-929 conditioned RPMI media. Cultured P.gingivalis or A
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A.muciniphila was added to the BMMϕ cultures at a multiplicity of infection (MOI) of 20:1 or 
40:1 respectively. BMMϕ were incubated with bacteria for 8h and supernatants were collected.
Gingival keratinocyte culture
Human telomerase immortalized gingival keratinocytes (TIGK) derived from gingival 
epithelium were maintained at 37°C and 5% CO2 in DermaLife K Serum-Free Keratinocyte 
Culture Medium (Fisher Scientific, Suwanee, GA, USA) as described previously (Moffatt-
Jauregui et al., 2013). TIGKs were seeded into 6-well plates at a concentration of 3-5x105 
cells/well. One day prior to experiments, cell culture medium was changed for fresh medium 
lacking antibiotics. TIGKs were incubated with cultured P.gingivalis or A.muciniphila added to 
the TIGK cultures at a multiplicity of infection (MOI) of 20:1 or 80:1 respectively for 24h. 
IL-8, IL-10 and IL-12 ELISA
Concentration of cytokines in culture supernatants were measured using eBioscience 
Mouse IL-10, Human IL-8 ELISA Ready-SET-Go!® kits (eBioscience, San Diego, CA, USA) 
and IL-12/IL-23 p40 (Total) Mouse Uncoated ELISA Kit (Invitrogen, Carlsbad, CA, USA) 
according to the manufacturer’s instructions.
RNA extraction and quantitative real-time PCR (qRT-PCR)
Total RNA from TIGK was isolated and purified with a RNeasy Mini kit according to the 
manufacturer’s instructions (Qiagen, Hilden, DE, USA). cDNA from total RNA was synthesized 
(50-100 ng RNA/20 μl) using a QuantiTect reverse transcription kit according to the 
manufacturer’s instructions (Qiagen). qRT-PCR was performed using the Taqman Fast Advanced 
Master Mix (Applied Biosystems, Foster City, CA, USA) and was run for the following genes 
using primer sets provided by ThermoFisher: E-cadherin (HS01023895_M1), Integrin-1 
(HS01127536_M1) and ZO-1 (Hs01551861_m1). The data were analyzed using QuantStudio 5 
software V1.4. The gene expression levels were normalized to GAPDH for TIGK and expressed 
relative to unstimulated controls following the 2-ΔΔCT method. 
Statistical Analysis
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Statistical analysis was performed using the GraphPad: Prism 7 software. Results were 
analyzed by one-way ANOVA with differences considered significant for p-value <0.05. All 
experiments have been performed at least 3 times in triplicates (biological and technical 
replicates).
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Results
A.muciniphila decreased P.gingivalis-induced soft tissue inflammation and calvarial bone 
destruction  
To determine if A.muciniphila could modulate the destructive effects induced by 
P.gingivalis, its impact on soft tissue inflammation and bone destruction was evaluated in a 
calvarial model of acute infection. While PBS injection did not induce any significant lesions, the 
injection of P.gingivalis induced a visible lesion affecting soft and hard tissues in both lean and 
obese mice (Figure 1). In contrast, the injection of A.muciniphila alone did not induce any 
significant lesion. Interestingly, simultaneous injection of P.gingivalis + A.muciniphila reduced 
the size of the lesion in lean and obese mice. At the histological level, qualitative analysis revealed 
that A.muciniphila administration significantly reduced soft tissue inflammation and osteoclast 
activity score (Figure 2). 
                                                                                 
Therapeutic administration of A.muciniphila reduced P.gingivalis induced alveolar bone 
destruction
To evaluate the potential therapeutic effect of A.muciniphila in the management of 
periodontitis, A.muciniphila was administered in an experimental periodontitis model. After 3 
weeks of P.gingivalis exposure, alveolar bone destruction was obtained as well as development of 
periodontal pockets (Figure 3). As expected, periodontal lesions induced by P.gingivalis were 
more pronounced in obese than in lean mice (p<0.05). After 2 weeks of A.muciniphila 
administration by oral gavage, a significant reduction of alveolar bone loss was measured (p<0.05) 
highlighting its protective role (Figure 3 B, C). Similar to the calvarial model of P.gingivalis 
infection, histological analysis showed reduced inflammatory scores and osteoclast activity in the 
interdental areas (p<0.01) (Figure 3 D-G). 
Presence of A.muciniphila modulated expression of P.gingivalis growth and virulence factors 
         To evaluate the mechanisms underlying the effects observed in vivo, we delved further into 
the interactions between P.gingivalis and A.muciniphila. A co-culture biofilm was cultured in vitro 
for 16h (Figure 4 A-D). It demonstrated in the monospecies condition that A.mucniphila showed 
very sparse attachment and little accumulation. However, the accumulation of A.muciniphila in 
combination with P.gingivalis showed a dramatic increase compared to A.muciniphila alone 
(p<0.001) emphasizing a potential interaction. This co-culture also decreased the expression of A
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P.gingivalis gingipains and was associated with an increased expression of A.muciniphila pili-like 
protein Amuc_1100 (Figure 4E). 
A.muciniphila induced an anti-inflammatory response in lean and obese BMMϕ
To determine the mechanisms underlying the reduced inflammation and alveolar bone 
destruction, BMMϕ isolated from lean or obese mice were challenged with P.gingivalis 
(MOI=20:1) and/or A.muciniphila (MOI=40:1) for 8h and supernatants were collected and 
analyzed for IL-10 (Figure 5 A-B ) and IL-12 (Figure 5 C-D) response. In both lean and obese 
BMMϕ, simultaneous exposure to A.muciniphila increased significantly anti-inflammatory IL-10 
secretion (131% in lean and 134% in obese vs P.gingivalis only). Regarding pro-inflammatory 
cytokines secretion, co-culture with A.muciniphila reduced significantly IL-12 level in both lean 
and obese BMMϕ (23% in lean and 50% in obese vs P.gingivalis only). Such results highlight, in 
lean and obese BMMϕ, a strong anti-inflammatory response associated to A.muciniphila 
administration. 
A.muciniphila improved the expression of tight junction and cell-cell adhesion markers and 
increased IL-8 expression in gingival epithelial cells
Due to their specific localization at the interface with oral biofilms, epithelial cells have a 
key role in the innate immune response and are considered as the first line of host defense such as 
described for epithelial cells in gut. In TIGK, as described in colonic cells, A.muciniphila 
increased mRNA expression of both cell-cell adhesion molecules (integrin-1 and E-cadherin) as 
well as tight junction molecules (ZO-1) in TIGK infected with P.gingivalis (Figure 6 A-C). 
Morevover, exposure to A.muciniphila increased IL-8 secretion, suggesting an enhanced anti-
infective response through recruitment of host-defense cells such as polymorphonuclear cells 
(Figure 6D). 
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Discussion 
In this study, a strong and consistent anti-inflammatory effect of A.muciniphila was demonstrated 
in the context of periodontal inflammation and alveolar bone destruction. In murine models associated 
with acute or chronic P.gingivalis exposure, the administration of A.muciniphila significantly decreased 
tissue destruction in both lean and obese animals, through modulation of the host response. In vitro, the 
administration of A.muciniphila improved the anti-inflammatory response of macrophages with 
increased IL-10 and reduced IL-12 secretion. Furthermore, the gingival epithelial cell response to 
A.muciniphila demonstrates its ability to improve cell adhesion and junctional structures is not limited to 
colonic epithelial cells. 
Periodontitis could be considered the consequence of a host-mediated disruption of microbial 
homeostasis (Bartold & Van Dyke, 2013). Therefore, new therapeutic strategies aim to control the 
inflammatory response and restore the balance between pro- and anti-inflammatory cytokines 
through the use of several drugs or active compounds (Alshammari et al., 2017; Morand et al., 
2016). However, the risk of side effects alleviates their systemic use and reinforces the need for 
new therapeutic tools.
A.muciniphila, a gram-negative anaerobe, has been primarily isolated from fecal samples 
(Derrien et al., 2004) and detected in whole human intestinal tracts in infants, adults and elderly 
subjects (Collado, Derrien, Isolauri, de Vos, & Salminen, 2007). Due to its association with 
healthy gut, a specific focus has been made on the potential anti-inflammatory properties of 
A.muciniphila in the context of several diseases such as diabetes (Zhang et al., 2018), obesity 
(Plovier et al., 2017) or osteoarthritis (Wang, Huang, Li, Xu, & Zeng, 2017). All have 
demonstrated that A.muciniphila contributes to a reduction of low-grade inflammation. 
Specifically, it has been shown that the addition of A.muciniphila to the intestinal microbiome 
down regulates LPS signaling through the reduction of downstream kinase p-JNK and an increase 
IB (nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha) (Zhao et 
al., 2017). Additionally, A.muciniphila reduces systemic inflammation through improved intestinal 
wall integrity, leading to a reduction of circulating LPS (Chelakkot et al., 2018; Everard et al., 
2013; Plovier et al., 2017). In the present study, we demonstrated that A.muciniphila was able to 
counteract the damaging inflammatory effects induced by P.gingivalis in lean and obese animals 
through induction of anti-inflammatory IL-10 expression and reduction of proinflammatory IL-12. 
Of notice is that exposure to A.muciniphila alone increased IL-12 secretion, a result congruent 
with published studies (Seregin et al., 2017; Ottman et al., 2017) and speculates that A.muciniphila A
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may negatively interact with  P.gingivalis.  
The question arises whether the administration of A.muciniphila has a direct effect on the 
P.gingivalis induced periodontitis or a systemic effect on the treated mice. In our mouse model, the 
relative abundance of A.muciniphila increased in the intestinal tract of treated animals (see 
Appendix), supporting the possibility of protection against systemic inflammation as previously 
observed in other disease models (Hiippala et al., 2018). Furthermore, we demonstrated a potential 
direct effect of A.muciniphila on P.gingivalis growth and virulence in the oral cavity, illustrated by 
the decrease of gingipains related markers. Such mechanisms should therefore be investigated, 
especially the impact on gingipains proteolytic activity, and will be helpful to define the optimal 
dose for administration of A.muciniphila.
A key process of the establishment of periodontal pocket is destruction of the junctional 
epithelium structural integrity induced by the modulation of the host-biofilm imbalance. This 
destruction includes disruption of cell-to-cell contacts and proliferation of epithelial ridges into the 
inflamed connective tissue  (Bosshardt, 2018). P.gingivalis is an invasive pathogen known to 
hijack epithelial cell machinery to improve its survival and enable its spread through connective 
tissue. For instance, it has been demonstrated that P.gingivalis induces changes related to the 
inflammatory response (Kocgozlu, Elkaim, Tenenbaum, & Werner, 2009); alters epithelial cell 
proliferation through modulation of apoptosis related pathways (Bugueno, Batool, Korah, 
Benkirane-Jessel, & Huck, 2018); and induces changes related to the expression of gingival 
epithelial junctions (Belibasakis, Kast, Thurnheer, Akdis, & Bostanci, 2015). The introduction of 
A.muciniphila reduces systemic inflammation through improved intestinal wall integrity leading to 
a reduction of circulating LPS (Plovier et al., 2017; Everard et al. 2013). Specifically, the secretion 
of extracellular vesicles by A.muciniphila increases protein expression of AMK, a kinase 
responsible for tight junction re-assembly and stability. In gut, the presence of A.muciniphila 
strengthened epithelial integrity, resulting in reduced inflammation. Increased barrier integrity is 
associated with an up-regulation of the expression of tight junction molecules such as ZO-1 as 
observed in animal models or in colonic cell culture (Ashrafian et al., 2019; Chelakkot et al., 
2018). Here, the same trend of expression was observed in TIGK regarding IL-8 secretion and 
adhesion or cell-to-cell junction molecules (integrin-1 and E-cadherin) as well as tight junction 
molecule ZO-1. 
Recently, supplementation of A.muciniphila in overweight and obese humans led to an 
improvement of several metabolic parameters such as insulinemia, insulin sensitivity, plasma total A
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cholesterol and was also associated to a significant weight loss. For the first time, safety and 
tolerability of A.muciniphila supplementation was demonstrated paving the way for using 
A.muciniphila in the management of inflammatory diseases (Depommier et al., 2019). 
This study illustrated, for the first time, the protective effects induced by A.muciniphila 
administration in the context of either acute P.gingivalis infection or periodontal destruction. Thus, the 
protective effects of A.muciniphila administration extend beyond the gastrointestinal tract. Its 
ability to modulate the host response through both an immune, and epithelial cell stand point may open 
consideration to its use as an adjunctive therapeutic agent to non-surgical periodontal treatment. 
However, all experiments have been conducted in the context of monobacterial infection with exposure 
of only P.gingivalis.  Since human periodontitis is triggered by a complex microbiome, A.muciniphila 
effects should be evaluated in the context of multispecies infection and  further studies should determine 
precisely the optimal dose and schedule of A.muciniphila administration for maximum immune 
protection. However, this study also provides proof-of-concept that specific bacteria known primarily as 
colonic microbes may contribute to improve a phenotype in a distant part of the gastrointestinal tract: 
the mouth.
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Figures legends
Figure 1: A.muciniphila reduced calvarial tissue destruction induced by P.gingivalis  injection. 
(A) Macroscopic view of the tissue destruction at calvarial site 3 days following injections of PBS 
(control), P.gingivalis alone (Pg), A.muciniphila alone (Akk), combined P.gingivalis and 
A.muciniphila (Pg+Akk) in lean and obese mice. (B) Quantitative evaluation of the size of the 
lesions in the lean mice over time. (C) Quantitative evaluation of the size of the lesion in the obese 
mice over time. Results were analyzed by ANOVA with differences considered significant at * 
p≤0.05 between groups (n=5/group). Pg: P.gingivalis injected group; Akk: A.muciniphila injected 
group; Pg+Akk: P.gingivalis + A.muciniphila injected concomitantly.
Figure 2: Histological evaluation of calvarial inflammation and bone destruction. (A) 
Histological staining (H & E and TRAP) of calvarial sections following P.gingivalis and 
A.muciniphila infection in lean mice. (B-C) Quantitative analysis of calvarial inflammation and 
osteoclast activity in lean mice. (D) Histological staining (H & E and TRAP) of calvarial sections 
following P.gingivalis and A.muciniphila infection in obese mice. (E-F) Quantitative analysis of 
calvarial inflammation and osteoclast activity in obese mice. All values are represented as mean 
±SEM (n=4). Comparison was made with P.gingivalis injected group. Results were analyzed by 
one-way ANOVA with differences considered significant at * p≤0.05, ** p≤0.01, *** p≤0.001. 
Pg: P.gingivalis injected group; Akk: A.muciniphila injected group; Pg+Akk: P.gingivalis + 
A.muciniphila injected concomitantly.
Figure 3: A.muciniphila reduced alveolar bone destruction and periodontal inflammation 
induced by P.gingivalis. (A) Flow-chart of the study. P.gingivalis-soaked ligatures were placed at 
maxillary molar sites and changed every 2 days over 3 weeks. P.gingivalis oral gavage was 
administered on alternate days when no ligatures were placed. After 3 weeks, ligatures were 
removed and P.gingivalis as well as A.muciniphila were administered by daily oral gavage for an 
additional 2 weeks. Pg: P.gingivalis; Akk: A.muciniphila. (B-C) Morphological analysis of 
alveolar bone destruction induced by P.gingivalis +/- A.muciniphila in lean (B) and obese (C) 
mice. Alveolar bone was stained with methylene blue. Determination of alveolar bone loss was 
performed by measurement of the distance between CEJ and ABC (µm). All values are 
represented as mean ±SEM (n=5/group), *:p<0.05 vs P.gingivalis only treated group. (D, F) A
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Histological staining (H & E and TRAP) of maxilla sections (between M1 and M2) in lean (D) 
and obese (F) mice. (E, G) Quantitative analysis of periodontal inflammation and osteoclast 
activity in lean (E) and obese (G) mice. All values are represented as mean ±SEM (n=5). 
Comparison was made with P.gingivalis group. Results were analyzed by one-way ANOVA with 
differences considered significant at *** p ≤0.001. Pg: P.gingivalis treated group; Pg+Akk: 
P.gingivalis + A.muciniphila treated group.
Figure 4: Co-culture of P.gingivalis  and A.muciniphila. (A-C) Both species have been cultured 
for 16h. After staining, an increase of AKK (red) could be observed in the presence of P. 
gingivalis (green). (D) Quantitation of the volume of A.muciniphila (m3) in presence of 
P.gingivalis. (E) mRNA expression of P.gingivalis gingipains (Rgp B, Rgp A, Kgp) and 
A.muciniphila Amuc_1100. *: p <0.05.  mRNA expression data is from three technical replicates.  
Bacteria were co-cultured for 3 hours prior to RNA isolation.
Figure 5: A.muciniphila modulates cytokine environment in vitro. (A-B) A.muciniphila induces 
IL-10 secretion in both lean and obese isolated BMMϕ. (C-D) Concomitant exposure to 
A.muciniphila decreases IL-12 secretion in both lean and obese isolated BMMϕ exposed to 
P.gingivalis. Cytokines expression analyzed via ELISA 8hrs post infection with either P.gingivalis 
alone (Pg) (MOI 20:1), A.muciniphila alone (Akk) (MOI 40:1), or A.muciniphila and P.gingivalis 
(Pg + Akk) in combination and in unstimulated cells (US) for 8h. All values, lean and obese, are 
expressed as a mean ± SEM (n = 3). Data was analyzed via One-way ANOVA. *: p <0.05, Pg vs 
Pg + Akk (D-E) or Akk vs Pg + Akk (E). 
Figure 6: A.muciniphila increases epithelial junction markers and IL-8 expression. (A-B-C) 
mRNA expression analysis was performed for TIGK cells exposed P.gingivalis alone (Pg) (MOI 
20:1), A.muciniphila alone (Akk) (MOI 80:1), or A.muciniphila and P.gingivalis (Pg + Akk) in 
combination and in unstimulated cells (US) for 24h. Relative expression of mRNA for cell 
adhesion molecules (E cadherin and Integrin -1 and tight junction molecule (ZO-1) was 
determined by quantitative real time PCR using TaqMan assays. Fold change was calculated using 
unstimulated cells as a baseline and GAPDH as a normalizing control. (D) A.muciniphila reverses A
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IL-8 cytokine paralysis associated with P.gingivalis infection. Cytokine expression analyzed via 
ELISA 24h post infections with Pg (MOI 20:1), Akk (MOI 80:1), or Pg +Akk. All data were 
analyzed via One-way ANOVA. Comparison was made with P.gingivalis infected group. 
*p≤0.05, ** p≤0.01, *** p≤0.001.  All values are expressed as a mean ± SEM (n = 3). 
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